ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,445Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 2094

$1.25M Total Retail Price of All Prescriptions

Rank: 45 out of 2094

484 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 18,343 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 754 729 1 3
AMLODIPINE BESYLATE 693 614 2 2
FUROSEMIDE 692 655 3 6
WARFARIN SODIUM 564 564 4 11
SIMVASTATIN 481 455 5 1
OMEPRAZOLE 480 436 6 4
METOPROLOL TARTRATE 479 419 7 10
LISINOPRIL 461 441 8 7
LACTULOSE 413 403 9 65
HYDROCODONE-ACETAMINOPHEN 386 301 S3 10 42
TRAMADOL HCL 385 351 11 33
NAMENDA 370 337 12 32
DONEPEZIL HCL 290 281 13 20
JANUVIA 282 254 14 35
METOPROLOL SUCCINATE 261 261 15 9
FENTANYL 257 250 S2 16 68
GABAPENTIN 256 230 17 23
ZOLPIDEM TARTRATE 242 221 18 14
POTASSIUM CHLORIDE 236 227 19 24
ATORVASTATIN CALCIUM 222 170 20 5
SERTRALINE HCL 221 208 21 26
TRAMADOL HCL-ACETAMINOPHEN 209 205 22 100
CARVEDILOL 204 191 23 19
METFORMIN HCL ER 194 136 24 67
MIRTAZAPINE 190 188 25 43
CARBIDOPA-LEVODOPA 189 189 26 102
ESCITALOPRAM OXALATE 185 162 27 46
LEVETIRACETAM 182 139 28 78
RISPERIDONE 179 156 29 56
ALBUTEROL SULFATE 175 124 30 90
DIVALPROEX SODIUM 174 174 31 69
MELOXICAM 172 162 32 49
CLOPIDOGREL 161 146 33 22
SPIRIVA 160 136 34 60
PAROXETINE HCL 159 155 35 77
GLIMEPIRIDE 152 132 36 31
DIOVAN 142 130 37 13
FAMOTIDINE 132 116 38 34
FLUTICASONE PROPIONATE 131 117 39 41
ISOSORBIDE MONONITRATE ER 129 125 40 57
CITALOPRAM HBR 127 127 41 47
PLAVIX 125 111 42 38
NEXIUM 120 100 43 16
DIGOXIN 117 106 44 51
LANTUS 117 93 44 66
CRESTOR 113 92 46 15
AZITHROMYCIN 112 108 47 27
TRAZODONE HCL 105 87 48 72
ALLOPURINOL 104 92 49 50
IPRATROPIUM BROMIDE 99 82 50 169
KLOR-CON M10 96 95 51 190
MUPIROCIN 94 92 52 117
NOVOLOG MIX 70-30 93 51 53 247
NOVOLOG 91 66 54 116
PRAVASTATIN SODIUM 90 89 55 18
CIPROFLOXACIN HCL 88 82 56 81
PANTOPRAZOLE SODIUM 85 82 57 37
ATENOLOL 85 85 57 21
CLOTRIMAZOLE-BETAMETHASONE 82 81 59 91
NITROGLYCERIN PATCH 79 79 60 101
QUETIAPINE FUMARATE 77 73 61 71
SINGULAIR 76 54 62 64
FLUOCINONIDE 75 75 63 238
SYMBICORT 73 58 64 149
LOSARTAN POTASSIUM 73 68 64 17
COMTAN 71 71 66 457
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 60 67 182
KLOR-CON M20 69 69 68 106
LIPITOR 68 61 69 39
GEMFIBROZIL 68 54 69 223
HYDRALAZINE HCL 68 52 69 89
LEVOCETIRIZINE DIHYDROCHLORIDE 67 50 72 169
NYSTATIN-TRIAMCINOLONE 65 64 73 207
MORPHINE SULFATE ER 64 38 S2 74 192
RESTASIS 64 41 74 251
METFORMIN HCL 63 60 76 8
ENALAPRIL MALEATE 61 49 77 25
LATANOPROST 61 61 77 153
BUDESONIDE 60 57 79 228
TRAVATAN Z 59 47 80 189
CLONIDINE 58 46 81 261
SANTYL 56 48 82 114
OXYBUTYNIN CHLORIDE ER 56 55 82 138
ALENDRONATE SODIUM 55 49 84 30
RAMIPRIL 54 54 85 48
GALANTAMINE HBR 52 40 86 351
HYDROXYZINE HCL 52 52 R 86 232
ADVAIR HFA 50 38 88 382
MONTELUKAST SODIUM 50 30 88 128
VESICARE 50 34 88 152
ONGLYZA 50 50 88 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.